In NPC cell lines and tissues, factors involved in the mTOR pathway, such as PI3K and AKT, are commonly activated [84-87] and mTOR inhibitors are validated and evaluated for clinical therapies [88-91]. Here, MTOR is linked to nasopharyngeal carcinoma.